Public Health Minister Anutin Charnvirakul has criticized Progressive Movement leader Thanathorn Juangroongruangkit, accusing him of not being grateful to the “Mother Land” for his…
LONDON (AP) — Britain authorized a COVID-19 vaccine for use Wednesday, greenlighting the first shot backed up by rigorous scientific review. The first vaccinations are expected within days — a major step toward eventually ending the pandemic.
The go-ahead for the vaccine from American drugmaker Pfizer and Germany’s BioNTech comes as the virus surges again in the United States and Europe, putting pressure on hospitals and forcing new rounds of restrictions that have devastated the global economy. Officials cautioned that several tough months still lie ahead, even in Britain, given the scale of the operation needed to vaccinate large swaths of the population.
Photo by Bryan R. Smith / AFP
US drug regulators gave emergency approval to a Covid-19 antibody therapy on Saturday and G20 nations pushed for global access to vaccines as the pandemic led to further closures in parts of the world.
With cases surpassing 12 million in the United States, the highest in the world, many Americans were nonetheless heading to airports to travel for next week’s Thanksgiving holiday despite health officials’ warnings to stay home.
Some US states were imposing new restrictions, including California, where a 10 pm to 5 am curfew was taking effect.
On the opposite side of the Atlantic, British Prime Minister Boris
In this handout photo released by the University of Oxford blood samples from coronavirus vaccine trials are handled inside the Jenner Institute in Oxford, England Thursday June 25, 2020. Scientists at Oxford University say their experimental coronavirus vaccine has been shown in an early trial to prompt a protective immune response in hundreds of people who got the shot. In research published Monday July 20, 2020 in the journal Lancet, scientists said that they found their experimental COVID-19 vaccine produced a dual immune response in people aged 18 to 55. (John Cairns, University of Oxford via AP)
LONDON (AP) — Scienti
Thailand may have its own COVID-19 vaccine in the next nine months, if every stage of the development proceeds smoothly, according to the country’s Public Health Minister Anutin Charnvirakul on Thursday.
The Minister, accompanied by Medical Science Department chief Dr. Opas Karnkawinpong, Food and Drug Administration Deputy Secretary-General Dr. Supachoke Tangvivat and Dr. Nakorn Premsri, Director of the National Vaccine Institute, were briefed on the development of the DNA type vaccine by Mr. Vitoon Wongharnkul and Dr. Pham Hong Thai, joint managing directors of Bionate Asia.
The vaccine is joint development between Bionate Asia and the National Vaccine Institute.
Mr. Anutin said he is pleased that the candidate vaccine has been successfully t